Clinical Trial Update: Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating cisplatin with nab-paclitaxel for Stage IIIA non-small cell lung cancer has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• CISPLATIN (cisplatin)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Stage IIIA Non-Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-05-11